Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06473103 · ClinicalTrials.gov registry record · NA
Investigation of Standard Excision Surgical Margins Using Two Photon Fluorescence Microscopy
A NA study of Basal Cell Carcinoma, sponsored by University of Rochester.
- Recruiting
- Registry status
- NA
- Development phase
- 52
- Enrollment target
- 1
- Study location
NCT06473103 is a NA study of Basal Cell Carcinoma that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 52 participants, below the 102-participant average among 24 other Basal Cell Carcinoma trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06473103, a NA study of Basal Cell Carcinoma, is actively recruiting participants, sponsored by University of Rochester.
- RECRUITING
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to compare the use of two photon fluorescence microscopy for detecting residual basal cell carcinoma during standard local excision.
Conditions Studied
Interventions
- DEVICE Two photon fluorescence microscopy imaging
Study Locations (1)
New York
- Rochester Dermatologic Surgery - Victor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2024-10-29 |
| Est. Completion | 2026-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06473103
The ClinicalTrials.gov registry entry for NCT06473103 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 102-participant average among 24 other Basal Cell Carcinoma trials with a reported enrollment target (49% lower). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Basal Cell Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Two photon fluorescence microscopy imaging is the first listed.
NCT06473103 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06473103 about?
NCT06473103 is a clinical study titled "Investigation of Standard Excision Surgical Margins Using Two Photon Fluorescence Microscopy". The goal of this clinical trial is to compare the use of two photon fluorescence microscopy for detecting residual basal cell carcinoma during standard local excision.
What is the current status of trial NCT06473103?
This trial is currently recruiting. It is a NA study. The enrollment target is 52 participants. The study started on 2024-10-29. Estimated completion is 2026-04.
What conditions does trial NCT06473103 study?
This clinical trial studies the following conditions: Basal Cell Carcinoma.
What interventions are being tested in trial NCT06473103?
The interventions under investigation include: Two photon fluorescence microscopy imaging (DEVICE).
Who is sponsoring clinical trial NCT06473103?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06473103 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Basal Cell Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma
RECRUITING · NA
-
Pilot Study of Line-Field Confocal Optical Coherence Tomography for Detection of Mohs Micrographic Surgery Margins of Basal Cell Carcinomas
RECRUITING · NA
-
Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery
COMPLETED · NA
-
Video-Based Treatment Options for Basal Cell Carcinoma
COMPLETED · NA
-
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
RECRUITING · Phase 2
-
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.